| 2024-10-10 16:41 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.01 | News Release200 | Mydecine Innovations suspended by Aquis |
| 2024-08-16 17:05 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.01 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-08-16 16:59 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.01 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-07-05 16:15 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine Innovations files 2023, Q1 2024 financials |
| 2024-07-05 12:48 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-07-05 12:48 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-07-02 08:07 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-07-02 08:01 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-06-13 16:22 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine to release 2023 results timing update June 21 |
| 2024-05-31 19:01 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine has no material changes |
| 2024-05-17 02:39 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine to release 2023 results timing update May 30 |
| 2024-05-02 19:42 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine Innovations receives MCTO |
| 2024-05-02 00:34 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.02 | News Release200 | Mydecine enters restructuring deals, arranges placement |
| 2024-04-25 18:51 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.02 | News Release200 | Mydecine to restate 2022 financials, applies for MCTO |
| 2024-04-15 17:24 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine closes two debt settlement agreements |
| 2024-04-08 16:11 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.02 | News Release200 | Mydecine arranges shares for debt deals |
| 2024-03-27 19:07 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.02 | News Release200 | Mydecine Innovations closes shares-for-debt deal |
| 2024-03-20 17:16 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine arranges $50,000 shares for debt settlement |
| 2024-02-22 16:15 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.013 | News Release200 | Mydecine closes $52,370 debt settlement |
| 2024-02-07 17:11 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine receives MYCO-005, -006 notices of allowance |
| 2024-02-05 03:03 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.015 | News Release200 | Mydecine to issue 2.61M shares for debt of $52,370 |
| 2024-02-02 16:11 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.02 | News Release200 | Mydecine's Stevenson-Moore resigns as director |
| 2023-12-18 09:17 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.105 | News Release200 | Mydecine receives notice of allowance for MYCO-005 |
| 2023-11-28 16:35 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.12 | News Release200 | Mydecine clarifies statements on special access program |
| 2023-11-16 02:05 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.135 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-16 01:58 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.135 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-10-31 11:45 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.12 | News Release200 | Mydecine files prospectus supplement; issues shares |
| 2023-10-26 11:17 | CC:MYCO | Mydecine Innovations Group Inc (2) | 0.145 | News Release200 | Mydecine talks drug discovery work with API |